Author: Customer Service

   Disclosure of the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the French Commercial Code and the Article 223-16 of the Règlement général de l’Autorité des marchés financiers   (Regulation of the French stock market authority) Company name of the issuer:         Renault S.A. 122 – 122 bis Avenue du Général Leclerc 92100 Boulogne-Billancourt (ISIN code: FR0000131906 – RNO)Date   Total number of issued shares     Total number of voting rightsApril 30, 2026     295,722,284     Theoretical number of voting rights(1): 405,532,284  Exercisable number of voting rights(2): 400,561,315(1)   Pursuant to Article 223-11 of the Règlement général de l’Autorité des marchés financiers, number calculated on the basis of all shares to which voting rights are attached, including shares for...

AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR22 MAY 2026 Please find below the Highlights and Chairman’s commentary from Richemont FY26 Annual Results Announcement. RICHEMONT DELIVERS STRONG SALES GROWTH AND SOLID RESULTSFOR THE YEAR ENDED 31 MARCH 2026 Group highlightsGroup sales at € 22.4 billion, up by 11% at constant rates (+5% actual) with continued momentum in Q4 at +13% Operating profit at € 4.5 billion including € 164 million of non-recurring costs, with strong top-line growth and cost discipline mitigating the effect of weaker main trading currencies and higher raw material costs Continued focus on cultivating Maisons’ long-term potential through sustained investment in craftsmanship, heritage preservation and strategic footprint expansion in distribution and manufacturingFinancial highlightsSales growth across all business...

AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR22 MAY 2026 RICHEMONT ANNOUNCES THE END OF THE SHARE BUYBACK PROGRAMME INITIATED IN MAY 2023 AND THE LAUNCH OF A NEW PROGRAMME   Richemont’s three-year share buyback programme announced on 12 May 2023 expired on 21 May 2026. Under the programme, the Company repurchased a total of 2’195’000 ‘A’ shares, representing 0.37% of the capital and 0.20% of the voting rights of Compagnie Financière Richemont SA. Richemont’s share purchase history can be found on the Company’s website at: https://www.richemont.com/investors/shareholder-information/share-buybacks/ In addition, Richemont announces a new programme starting 26 May 2026 to buy back up to 10 million ‘A’ shares, representing 1.69% of the capital and 0.93% of the voting rights of the Company. Purchases will be effected through ‘A’ share purchases...

OSE Immunotherapeutics Reports Positive Topline Results of TEDOVA Phase 2 Trial with Tedopi® in Recurrent Ovarian CancerTopline results to be presented by Alexandra Leary, MD, PhD, on May 30, 2026, at the 2026 Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago OSE Immunotherapeutics to host a KOL webcast on June 10, 2026Nantes, France, May 22, 2026 – 7:30am CET – OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE), a clinical-stage biotech company dedicated to developing first-in-class therapies in immuno-oncology and immuno-inflammation, today announced the release of the abstract selected for an oral presentation at the upcoming ASCO 2026Annual Meeting, unveiling topline results from the TEDOVA/GINECO-OV244b/ENGOT-ov58 academic, international, Phase 2 trial sponsored by ARCAGY-GINECO and evaluating...

AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR22 MAY 2026 RICHEMONT PUBLISHES FY26 ANNUAL REPORT AND ACCOUNTSRichemont has today published its Annual Report and Accounts for the year ended 31 March 2026. The Annual Report includes the Chairman’s review to shareholders, the annual consolidated and statutory financial statements, and the corresponding audit reports. It reflects the information provided in Richemont’s full-year 2026 results announcement issued today. Richemont expects to publish the combined Annual Report with the Compensation Report, the Corporate Governance Report and the Business review for the year ended 31 March 2026, on 29 May 2026. At that time, it will also publish the Richemont Non-Financial Report 2026. The Annual Report is available for download on the Company’s website athttps://www.richemont.com/media/045hlucv/richemont-fy26-annual-report-and-accounts.pdf About...

Provides immediate new financing to support the Company’s next strategic milestones Strengthens shareholders’ equity and improves the Company’s financial structure Supports the continuation of ZEPIZURE® regulatory activities, including upcoming EUA-related steps, and the ramp-up of production readiness throughout 2026 May provide additional funding upon exercise of the warrants Total subscription price of €2.33 per unit, including approximately €1.704 for the share component and €0.626 for the warrant componentDIJON, FRANCE, May 22, 2026 – 07h30 (CET) – CROSSJECT (ISIN: FR0011716265; Euronext: ALCJ), a specialty pharmaceutical company developing products for emergency situations based on its proprietary ZENEO® needle-free auto-injector technology, currently in the advanced stages of development and registration for ZEPIZURE®, an...

PRESS RELEASEMay 22, 2026RENAULT GROUP SUCCESSFULLY ISSUES DUAL-TRANCHE SAMURAI BONDS FOR A NOMINAL AMOUNT OF ¥159 BILLION Boulogne-Billancourt, May 22nd, 2026 – Renault Group announces the successful issuance of dual-tranche Samurai bonds for a total nominal amount of ¥159 billion. The transaction is structured as follows:a tranche dedicated to retail investors for an amount of ¥100 billion, maturing in 2030 and carrying a coupon of 3.02%; a tranche dedicated to institutional investors for an amount of ¥59 billion, maturing in 2030 and carrying a coupon of 3.02%.This transaction represents Renault Group’s inaugural issuance featuring both a retail investor tranche and an institutional investor tranche. With this achievement, Renault Group sets a new benchmark as the first non-domestic corporate to launch a dual-tranche Retail...

FRONTLINE PLC REPORTS RESULTS FOR THE FIRST QUARTER ENDED MARCH 31, 2026 Frontline plc (the “Company”, “Frontline,” “we,” “us,” or “our”), today reported unaudited results for the three months ended March 31, 2026: HighlightsProfit of $559.1 million, or $2.51 per share for the first quarter of 2026. Adjusted profit of $344.9 million for the first quarter of 2026, the strongest since the fourth quarter of 2004, or $1.55 per share. Declared a cash dividend of $1.55 per share for the first quarter of 2026. Reported revenues of $714.2 million for the first quarter of 2026. Achieved average daily spot time charter equivalent earnings (“TCEs”)1 for VLCCs, Suezmax tankers and LR2/Aframax tankers in the first quarter of $103,500, $72,400 and $50,700 per day, respectively. Delivered eight of our oldest first-generation ECO VLCCs,...